ask="51.50"
ask_size="100"
average_daily_volume="405015"
bid="42.10"
bid_size="200"
book_value="14.89"
change="-0.52"
change_from_200_day_moving_average="-5.88"
change_from_50_day_moving_average="-5.50"
change_from_52_week_high="-16.75"
change_From_52_week_low="16.22"
change_in_percent="-1.16%"
close="44.23"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24015000"
high="44.75"
high_52_weeks="60.98"
last_trade_date="1/30/2017"
last_trade_price="44.23"
last_trade_size="20005"
last_trade_time="4:00pm"
low="43.37"
low_52_weeks="28.01"
market_capitalization="1.20B"
moving_average_200_day="50.11"
moving_average_50_day="49.73"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="44.43"
pe_ratio="4.94"
peg_ratio="0.32"
percent_change_from_200_day_moving_average="-11.74%"
percent_change_from_50_day_moving_average="-11.06%"
percent_change_from_52_week_high="-27.47%"
percent_change_from_52_week_low="+57.91%"
previous_close="44.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.01"
price_per_sales="3.15"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.09"
stock_exchange="NMS"
symbol="FPRX"
volume="278865"
weeks_range_52="28.01 - 60.98"
